These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 30463977)
1. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation. Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977 [TBL] [Abstract][Full Text] [Related]
2. A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus. Zhu Y; Li T; Ramos da Silva S; Lee JJ; Lu C; Eoh H; Jung JU; Gao SJ mBio; 2017 Aug; 8(4):. PubMed ID: 28811348 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3. Rivera-Soto R; Dissinger NJ; Damania B J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855 [TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling. Chen M; Sun F; Han L; Qu Z Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260 [TBL] [Abstract][Full Text] [Related]
5. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells. Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437 [TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin. Markazi A; Bracci PM; McGrath M; Gao SJ mBio; 2020 Nov; 11(6):. PubMed ID: 33173008 [TBL] [Abstract][Full Text] [Related]
7. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. Punjabi AS; Carroll PA; Chen L; Lagunoff M J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100 [TBL] [Abstract][Full Text] [Related]
8. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M J Virol; 2017 May; 91(10):. PubMed ID: 28275189 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis. Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660 [TBL] [Abstract][Full Text] [Related]
10. KSHV hijacks FoxO1 to promote cell proliferation and cellular transformation by antagonizing oxidative stress. Li T; Gao SJ J Med Virol; 2023 Mar; 95(3):e28676. PubMed ID: 36929740 [TBL] [Abstract][Full Text] [Related]
11. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis. Liu X; Happel C; Ziegelbauer JM J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859 [TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells. Gruffaz M; Yuan H; Meng W; Liu H; Bae S; Kim JS; Lu C; Huang Y; Gao SJ mBio; 2019 May; 10(3):. PubMed ID: 31088931 [TBL] [Abstract][Full Text] [Related]
13. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM mBio; 2017 Jul; 8(4):. PubMed ID: 28698273 [TBL] [Abstract][Full Text] [Related]